by Richard Daverman, PhD
September 22, 2012 -- China’s sequencing giant, BGI, paid $117 million to buy Complete Genomics, a California-based gene sequencing company; Alliance Boots of the UK purchased a 12% stake Nanjing Pharma for $91 million in a drug distribution tie-up; China Cord Blood received a $50 million capital infusion from its corporate parent, Golden Meditech Holdings; NovaBay Pharma expanded its distribution partnership with Pioneer Pharma to include Southeast Asia; China ordered an average 17% reduction in the maximum retail prices of 95 cancer, immunology and blood-related drugs, many of them produced by foreign drugmakers; Johnson & Johnson will set up four innovation centers around the globe – one of them in China (see story); and a spinal stabilization device from Shanghai Kinetic Medical was approved for use in the US by the FDA. More details….
Stock Symbols: (NSDQ: GNOM) (SHA: 600713) (NYSE: CO) (HK: 801; TW: 910801) (NYSE: NBY) (NYSE: JNJ) (SHE: 300326)
